Germany’s Federal Joint Committee (G-BA) have proposed changes to medical cannabis prescription process

Business of Cannabis reports Germany’s Federal Joint Committee (G-BA) last week proposed significant changes to the medical cannabis prescription process, set to have a major impact on the country’s already booming market. Germany’s private or ‘self funded’ medical cannabis market has exploded since the introduction of CanG on April 01, which removed cannabis from the […]